CMP Pharma’s portfolio of FDA-approved ready-made oral liquid products: Tadliq® (Tadalafil) Oral Suspension, 20 mg/5m, the first and only FDA-approved liquid oral suspension of Tadalafil for adult patients with difficulty swallowing, Norliqva® (Amlodipine) Oral Solution, 1mg/mL, the first FDA-approved liquid solution for hypertension in adults and children 6 years and older, and CaroSpir® (Spironolactone) Oral Suspension, 25 mg/5mL the first and only FDA-approved oral suspension of the potassium-sparing diuretic spironolactone.
Additional Info
First-time Exhibitor:
Yes